David Larsen

BTIG | Healthcare

David Larsen is an analyst from BTIG specializing in the Healthcare sector. Ranked #1094 out of 4643 analysts, they have issued 42 stock ratings with a success rate of 91.97% and an average return of 15.27%.

David Larsen has a well-established track record, with 42 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 91.97% and an average return of 15.27%, underscoring their expertise and ability to identify winning opportunities for investors.

#1094

Out of 4643

42

Total Ratings

+91.97%

Success Rate

+15.27%

Average Return

Recent Ratings Analysis

MDLN

May 07, 2026

Target

$55.00

Current

$42.01

Performance

—

David Larsen rated MDLN as Buy on May 07, 2026, setting a price target of 55. Shares have remained stable near 42.01, leaving the 55 target still in play.

CYRX

May 05, 2026

Target

$17.00

Current

$12.69

Performance

4.10%

On May 05, 2026, CYRX was given a Buy rating by David Larsen, with a target price of 17. The stock traded sideways with a 4.10% move, keeping the bullish thesis unresolved.

LFMD

May 04, 2026

Target

$10.00

Current

$5.27

Performance

3.54%

LFMD received a Buy rating from David Larsen on May 04, 2026, aiming for 10. Price action was muted, as shares hovered around 5.27 despite the bullish outlook.

BTSG

May 04, 2026

Target

$65.00

Current

$52.74

Performance

-1.49%

On May 04, 2026, David Larsen published a Buy outlook on BTSG, with a target of 65. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 52.74.

TOI

Mar 09, 2026

Target

$7.00

Current

$3.80

Performance

39.19%

David Larsen on Mar 09, 2026 assigned TOI a Buy rating, with a price target of 7. The Buy call aligned well with market performance, producing a gain of 39.19%.

PGNY

Mar 05, 2026

Target

$35.00

Current

$18.70

Performance

—

On Mar 05, 2026, David Larsen reaffirmed PGNY with a Buy rating, targeting 35. Market indecision has kept the 35 target in a holding pattern.

EVH

Feb 25, 2026

Target

$10.00

Current

$3.83

Performance

21.97%

EVH was rated Buy by David Larsen on Feb 25, 2026, with a price objective of 10. A bullish response from the market helped close the gap of 6.17 to the target.

HIMS

Feb 24, 2026

Target

—

Current

$26.88

Performance

73.87%

On Feb 24, 2026, David Larsen initiated coverage on HIMS with a Neutral rating and target of null. The Hold stance underestimated the stock’s strength as it gained 73.87%.

CCSI

Feb 17, 2026

Target

$40.00

Current

$26.73

Performance

-6.93%

David Larsen issued a Buy recommendation for CCSI on Feb 17, 2026, price target set at 40. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

HQY

Feb 17, 2026

Target

$130.00

Current

$83.25

Performance

11.96%

On Feb 17, 2026, HQY was evaluated by David Larsen, who gave a Buy rating and target of 130. This case illustrates how a timely bullish rating can translate into tangible gains of 11.96%.

DOCS

Feb 06, 2026

Target

$50.00

Current

$25.69

Performance

-7.36%

David Larsen rated DOCS as Buy on Feb 06, 2026, setting a price target of 50. The stock has underperformed, dropping 7.36% despite the bullish target of 50.

LFST

Feb 02, 2026

Target

$11.00

Current

$7.36

Performance

2.51%

On Feb 02, 2026, LFST was given a Buy rating by David Larsen, with a target price of 11. The stock traded sideways with a 2.51% move, keeping the bullish thesis unresolved.

ASTH

Feb 02, 2026

Target

$40.00

Current

$35.25

Performance

57.93%

ASTH received a Buy rating from David Larsen on Feb 02, 2026, aiming for 40. Momentum has favored the Buy call, with shares climbing from 35.25 to 35.25, rewarding those who trusted the recommendation.

SLP

Dec 18, 2025

Target

—

Current

$15.88

Performance

—

On Dec 18, 2025, David Larsen published a Neutral outlook on SLP, with a target of null. Sideways action left the Hold view intact, with no major move since 15.88.

PIII

Dec 12, 2025

Target

—

Current

$2.86

Performance

-44.89%

David Larsen on Dec 12, 2025 assigned PIII a Neutral rating, with a price target of null. The call successfully avoided chasing as shares lost 44.89%.

AGL

Dec 12, 2025

Target

—

Current

$27.85

Performance

54.94%

On Dec 12, 2025, David Larsen reaffirmed AGL with a Neutral rating, targeting null. Market strength beyond 27.85 went further than the conservative outlook suggested.

VEEV

Nov 21, 2025

Target

$340.00

Current

$167.29

Performance

-31.46%

VEEV was rated Buy by David Larsen on Nov 21, 2025, with a price objective of 340. This case shows how bullish projections can fail, with the stock now below 167.29.

HCAT

Sep 05, 2025

Target

—

Current

$1.57

Performance

-53.55%

On Sep 05, 2025, David Larsen initiated coverage on HCAT with a Neutral rating and target of null. The rating matched the stock’s inability to hold above 1.57.

DH

Sep 17, 2024

Target

$7.00

Current

$0.94

Performance

-80.06%

David Larsen issued a Buy recommendation for DH on Sep 17, 2024, price target set at 7. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

DCGO

May 09, 2024

Target

$7.00

Current

$0.62

Performance

-79.81%

On May 09, 2024, DCGO was evaluated by David Larsen, who gave a Buy rating and target of 7. Investors saw limited payoff as shares fell short of the 7 target.

Frequency Asked Questions

Who is David Larsen?

David Larsen is an analyst from BTIG specializing in the Healthcare sector.

What is David Larsen's success rate?

David Larsen currently has a success rate of +91.97%.

How many ratings has David Larsen issued?

David Larsen has issued 42 stock ratings so far.

What is the average return of David Larsen's calls?

Their stock ratings have generated an average return of +15.27%.

What is David Larsen's ranking?

David Larsen is ranked #1094 out of 4643 analysts.

What types of ratings does David Larsen give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Larsen?

You can follow David Larsen by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Larsen?

Their latest rating was a Buy on MDLN issued on 2026-05-07.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep